DATE: October 09, 2020
TIME: 08:00am PDT
As the primary diagnostic tool for infectious diseases, traditional culture techniques are coming under scrutiny for failing to universally detect infections resulting from biofilms, viable but non-culturable (VBNC) bacteria, and persister microbial cells in patients. In the presence of infectious symptoms and other biomarkers suggestive of active disease, such negative culture results may delay appropriate treatment or result in treatment failure with an antimicrobial agent insufficient to resolve the infection. Advances in the speed, affordability, and utility of information offered from Next Generation Sequencing (NGS) results made available to the clinical laboratorian and to treating clinician argue for an expanded role for coincident culture along with NGS testing in those patients with either an acute or a chronic infection. In this webinar, we will discuss:
In this webinar we will discuss:
Webinars will be available for unlimited on-demand viewing after live event.